1. Mitoxantrone, fluorouracil, and L-folinic acid in anthracycline-pretreated metastatic breast cancer patients

   • Romeo Bascioni
   • Francesca Giorgi
   • Enrica Testa

   OriginalPaper Pages: 205 - 210

2. Bone marrow fibroblastic progenitors in patients with advanced breast cancer

   • Norma A. Chasseing
   • Yolanda G. Trejo
   • Lia S. Rumi

   OriginalPaper Pages: 211 - 218

3. Predictors of response to second-line endocrine therapy for breast cancer

   • K.L. Cheung
   • P.C. Willsher
   • J.F.R. Robertson

   OriginalPaper Pages: 219 - 224

4. Consistency of patient- and doctor-assessed cosmetic outcome after conservative treatment of breast cancer

   • Holli Kaija
   • Saaristo Rauni
   • Hakama Matti

   OriginalPaper Pages: 225 - 228

5. Eicosapentaenoic acid and sulphur substituted fatty acid analogues inhibit the proliferation of human breast cancer cells in culture

   • Farzaad Abdi-Dezfuli
   • Livar Frøyland
   • Rolf K. Berge

   OriginalPaper Pages: 229 - 239

6. Prognostic significance of estrogen receptors in 405 primary breast cancers: a comparison of immunohistochemical and biochemical methods

   • A. Molino
   • R. Micciolo
   • G.L. Cetto

   OriginalPaper Pages: 241 - 249

7. A phase III comparison of two toremifene doses to tamoxifen in postmenopausal women with advanced breast cancer

   • Michael Gershanovich
   • August Garin
   • Eastern European Study Group

   OriginalPaper Pages: 251 - 262

8. Followup after 11 years – update of mortality results in the Stockholm mammographic screening trial

   • Jan Frisell
   • Elisabet Lidbrink
   • Lars-Erik Rutqvist

   OriginalPaper Pages: 263 - 270